Featured
FDA Approves Gene Therapy for Treatment of Spinal Muscular Atrophy
FDA Approves New Safety Warning and Revised Indication that Limits Use for Elevidys Following Reports of Fatal Liver Injury
Dystrophic Epidermolysis Bullosa (DEB): What You Need to Know

Dystrophic epidermolysis bullosa (DEB) is a condition caused by mutations in gene COL7A in which skin becomes fragile and prone to blistering. For people with DEB, any injury or friction on the skin can lead to the formation of painful blisters.